-
1
-
-
67651184095
-
A case of aripiprazole and tardive dyskinesia
-
online first 10.1177/0269881108089591
-
Abbasian, C, Power, P (2008) A case of aripiprazole and tardive dyskinesia. J Psyehopharmacol(online first) 10.1177/0269881108089591.
-
(2008)
J Psyehopharmacol
-
-
Abbasian, C.1
Power, P.2
-
2
-
-
0003893075
-
-
Alcohol Drug Abuse and Mental Health Administration Washington, DC: Department of Health, Education and Welfare.
-
Alcohol Drug Abuse and Mental Health Administration (1974) Abnormal involuntary movement scale (AIMS). Washington, DC: Department of Health, Education and Welfare.
-
(1974)
Abnormal Involuntary Movement Scale (AIMS)
-
-
-
3
-
-
33645851672
-
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism, in the DRD3 gene: A meta analysis
-
Bakker, PR, van Harten, PN, van Os, J (2006) Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism, in the DRD3 gene: a meta analysis. Schizophr Res 83: 185-192.
-
(2006)
Schizophr Res
, vol.83
, pp. 185-192
-
-
Bakker, P.R.1
Van Harten, P.N.2
Van Os, J.3
-
4
-
-
0036089687
-
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
-
DOI 10.1124/jpet.102.033175
-
Burris, KD, Molski, T, Xu, C, Ryan, E, Tottori, K, Kikuchi, T, et al. (2002) Aripiprazole a novel antipsychotic, is a high affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302: 381-389. (Pubitemid 34680462)
-
(2002)
Journal of Pharmacology and Experimental Therapeutics
, vol.302
, Issue.1
, pp. 381-389
-
-
Burris, K.D.1
Molski, T.F.2
Xu, C.3
Ryan, E.4
Tottori, K.5
Kikuchi, T.6
Yocca, F.D.7
Molinoff, P.B.8
-
5
-
-
34447518468
-
Newer antipsychotics and the rabbit syndrome
-
Catena, Dell'osso, M, Fagiolini, A, Ducci, F, Masalehdan, A, Ciapparelli, A, Frank, E (2007) Newer antipsychotics and the rabbit syndrome. Clin Pract Epidemol Ment Health. 3: 6-12.
-
(2007)
Clin Pract Epidemol Ment Health
, vol.3
, pp. 6-12
-
-
Catena1
Dell'Osso, M.2
Fagiolini, A.3
Ducci, F.4
Masalehdan, A.5
Ciapparelli, A.6
Frank, E.7
-
6
-
-
33750628479
-
A model of anticholinergic activity of atypical antipsychotic medications
-
DOI 10.1016/j.schres.2006.07.011, PII S092099640600315X
-
Chew, ML, Mulsant, BH, Pollock, BG, Lehman, ME, Greenspan, A, Kirshner, MA, et al. (2006) A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res 88: 63-72. (Pubitemid 44693242)
-
(2006)
Schizophrenia Research
, vol.88
, Issue.1-3
, pp. 63-72
-
-
Chew, M.L.1
Mulsant, B.H.2
Pollock, B.G.3
Lehman, M.E.4
Greenspan, A.5
Kirshner, M.A.6
Bies, R.R.7
Kapur, S.8
Gharabawi, G.9
-
7
-
-
0034435268
-
Rabbit syndrome treated with olanzapine
-
Durst, R, Katz, G, Zilsin, J, Raskin, S, Kalman, I (2000) Rabbit syndrome treated with olanzapine. Br J Psychiatry 176: 193.
-
(2000)
Br J Psychiatry
, vol.176
, pp. 193
-
-
Durst, R.1
Katz, G.2
Zilsin, J.3
Raskin, S.4
Kalman, I.5
-
8
-
-
47249120920
-
Aripiprazoleinduced rabbit syndrome in a drug-naive schizophrenic patient
-
Gonidakis, F, Ploubidis, D, Papadimitriou, G (2008) Aripiprazoleinduced rabbit syndrome in a drug-naive schizophrenic patient. Schizophr Res 103: 341-342.
-
(2008)
Schizophr Res
, vol.103
, pp. 341-342
-
-
Gonidakis, F.1
Ploubidis, D.2
Papadimitriou, G.3
-
9
-
-
4644250170
-
Aripiprazole: Review of its pharmacology and therapeutic use in psychiatric disorders
-
DOI 10.1080/10401230490487007
-
Gupta, S, Masand, P (2004) Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 16: 155-166. (Pubitemid 39281275)
-
(2004)
Annals of Clinical Psychiatry
, vol.16
, Issue.3
, pp. 155-166
-
-
Gupta, S.1
Masand, P.2
-
10
-
-
0034100581
-
Tardive dyskinesia in older patients
-
Jeste, DV (2000) Tardive dyskinesia in older patients. J Clin Psychiatry 61: 27-32.
-
(2000)
J Clin Psychiatry
, vol.61
, pp. 27-32
-
-
Jeste, D.V.1
-
11
-
-
0034025771
-
2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
-
DOI 10.1176/appi.ajp.157.4.514
-
Kapur, S, Zipursky, R, Jones, C, Remington, G, Houle, S (2000) Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157: 514-520. (Pubitemid 30191189)
-
(2000)
American Journal of Psychiatry
, vol.157
, Issue.4
, pp. 514-520
-
-
Kapur, S.1
Zipursky, R.2
Jones, C.3
Remington, G.4
Houle, S.5
-
12
-
-
34648830603
-
1A receptor occupancy in patients with schizophrenia: A triple tracer PET study
-
DOI 10.1176/appi.ajp.2007.06091479
-
Mamo, D, Graff, A, Mizrahi, R, Shammi, CM, Romeyer, F, Kapur, S (2007) Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 164: 1411-1417. (Pubitemid 47461142)
-
(2007)
American Journal of Psychiatry
, vol.164
, Issue.9
, pp. 1411-1417
-
-
Mamo, D.1
Graff, A.2
Mizrahi, R.3
Shammi, C.M.4
Romeyer, F.5
Kapur, S.6
-
13
-
-
19244366218
-
Aripiprazole-induced rabbit syndrome
-
Mendhekar, DN (2004) Aripiprazole-induced rabbit syndrome. Aust N Z J Psychiatry 38: 561.
-
(2004)
Aust N Z J Psychiatry
, vol.38
, pp. 561
-
-
Mendhekar, D.N.1
-
14
-
-
0038488945
-
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
-
DOI 10.1001/archpsyc.60.7.681
-
Potkin, SG, Saha, AR, Kujawa, MJ, Carson, WH, Ali, M, Stock, E, et al. (2003) Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs. placebo in patients with, schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 60: 681.-690. (Pubitemid 36818630)
-
(2003)
Archives of General Psychiatry
, vol.60
, Issue.7
, pp. 681-690
-
-
Potkin, S.G.1
Saha, A.R.2
Kujawa, M.J.3
Carson, W.H.4
Ali, M.5
Stock, E.6
Stringfellow, J.7
Ingenito, G.8
Marder, S.R.9
-
15
-
-
33745019145
-
A case of Aripiprazole and extra-pyramidal side effects
-
DOI 10.1177/0269881106060194
-
Salmoiraghi, A, Odiyoor, M (2006) A. case of aripiprazole and extrapyramidal side effects. J Psychopharmacol 20: 592-593. (Pubitemid 43875191)
-
(2006)
Journal of Psychopharmacology
, vol.20
, Issue.4
, pp. 592-593
-
-
Salmoiraghi, A.1
Odiyoor, M.2
-
16
-
-
1642364505
-
Antipsychotic-induced rabbit syndrome: Epidemiology, management and pathophysiology
-
DOI 10.2165/00023210-200418040-00002
-
Schwartz, M, Hocherman, S (2004) Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology. CNS Drugs 18: 213-220. (Pubitemid 38393432)
-
(2004)
CNS Drugs
, vol.18
, Issue.4
, pp. 213-220
-
-
Schwartz, M.1
Hocherman, S.2
-
17
-
-
0029031479
-
Rabbit syndrome and tardive dyskinesia two complications of chronic neuroleptic treatment
-
Schwartz, M, Weller, B, Erdreich, M, Sharf, B (1995) Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment. J Clin Psychiatry 56: 212.
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 212
-
-
Schwartz, M.1
Weller, B.2
Erdreich, M.3
Sharf, B.4
-
18
-
-
0000508099
-
Drug induced extrapyramidal disorders
-
Simpson, G, Angus, J (1970) Drug induced extrapyramidal disorders. Acta Psychiatr Scand 45: 11-19.
-
(1970)
Acta Psychiatr Scand
, vol.45
, pp. 11-19
-
-
Simpson, G.1
Angus, J.2
-
20
-
-
0026656349
-
The rabbit syndrome and antiparkinsonian medication in schizophrenic patients
-
Wada, Y, Yamaguehi, N (1992) The rabbit syndrome and antiparkinsonian medication in schizophrenic patients. Neuropsychobiology 25: 149-152.
-
(1992)
Neuropsychobiology
, vol.25
, pp. 149-152
-
-
Wada, Y.1
Yamaguehi, N.2
|